Reviewers’ Notes The longer a person has type 2 diabetes, the more likely they may be to experience changes in brain structure, a Michigan Medicine study finds. Researchers analyzing data from 51 middle-aged Pima American Indians living with type 2 diabetes used a series of memory and language tests developed by the National Institutes of Health, called the NIH Toolbox […]
» Read more
Imagine a world where you could control your sense of time. Where trips to the dentist flew by in a second and holidays felt like they lasted forever. Time altering pills may sound like science fiction but the time warping effects of psychoactive drugs suggest that deliberate time manipulation may be possible. Drug induced time-warps are a widely reported phenomenon […]
» Read more
Reviewers’ Notes Scientists at Université Laval and the University of Lethbridge have succeeded in reversing certain cognitive manifestations associated with Alzheimer's disease in an animal model of the disease. Their results have been published in the scientific journal Brain. Although this has yet to be demonstrated in humans, we believe that the mechanism we have uncovered constitutes a very interesting […]
» Read more
At this time of year many of us are enjoying or about to enjoy holidays—day trips, the beach, the mountains, a change of scene. Even if we don’t leave our home, summer brings with it a number of risks that can affect the health of our eyes and can spoil the season if we don’t adhere to a few basic […]
» Read more
Allergy misconceptions Barriers to delabeling Improving patient communication Next steps Source: Read Full Article
» Read more
Pharmaceutical titan Novo Nordisk rakes in record £4.5BILLION due to success of its game-changing weight loss jabs Ozempic and Wegovy Danish pharma titan Novo Nordisk raked in £4.5billion in the first half of 2023 Bosses of the firm credited sky-high demand for its weekly semaglutide jabs Ozempic’s maker today announced its profits have reached record high thanks to the huge […]
» Read more
MaxCyte, Inc., clindamycin iv drug study a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announced the signing of a strategic partnership with Prime Medicine, Inc., a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies. Under the […]
» Read more
In a recent study published in Vaccine, researchers investigated clinically significant predictors of coronavirus disease 2019 (COVID-19) vaccination uptake among individuals with social and medical susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, residing in the Essex County of New Jersey. Study: Individual and structural determinants of COVID-19 vaccine uptake in a marginalized community in the United States. […]
» Read more
(Reuters) -Illumina Inc cut annual profit forecast, in a sign that a funding crunch among its biotech and pharmaceutical clients is expected to weigh on sales for its genetic testing tools and diagnostics products.FILE PHOTO: The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake/File PhotoShares were down nearly 6% in […]
» Read more
The latest clinical practice guideline for managing patients with chronic coronary disease (CCD) takes an evidence-based and patient-centered approach to care and includes key updates on revascularization, beta-blocker use, and routine functional and anatomic testing. Developed by the American Heart Association (AHA), the American College of Cardiology (ACC), and other specialty societies, the 2023 guideline both updates and consolidates ACC/AHA […]
» Read more